46 results on '"Uraki, Ryuta"'
Search Results
2. An mRNA vaccine encoding the SARS-CoV-2 receptor-binding domain protects mice from various Omicron variants
3. Drug susceptibility and the potential for drug-resistant SARS-CoV-2 emergence in immunocompromised animals
4. In vitro and in vivo characterization of SARS-CoV-2 resistance to ensitrelvir
5. Antibody induction and immune response in nasal cavity by third dose of SARS-CoV-2 mRNA vaccination
6. Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolates
7. Plasminogen activator inhibitor 1 is not a major causative factor for exacerbation in a mouse model of SARS-CoV-2 infection
8. Antiviral efficacy against and replicative fitness of an XBB.1.9.1 clinical isolate
9. Characterization of SARS-CoV-2 Omicron BA.4 and BA.5 isolates in rodents
10. Transmission and re-infection of Omicron variant XBB.1.5 in hamsters
11. In SARS-CoV-2 delta variants, Spike-P681R and D950N promote membrane fusion, Spike-P681R enhances spike cleavage, but neither substitution affects pathogenicity in hamsters
12. Therapeutic efficacy of monoclonal antibodies and antivirals against SARS-CoV-2 Omicron BA.1 in Syrian hamsters
13. Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2
14. SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters
15. REPLY TO SLOMINSKI ET AL. : UVB irradiation induces proenkephalin⁺ regulatory T cells with a wound-healing function
16. Proenkephalin⁺ regulatory T cells expanded by ultraviolet B exposure maintain skin homeostasis with a healing function
17. Loss of the TAM Receptor Axl Ameliorates Severe Zika Virus Pathogenesis and Reduces Apoptosis in Microglia
18. Differences in the ease with which mutant viruses escape from human monoclonal antibodies against the HA stem of influenza A virus
19. Aedes aegypti AgBR1 antibodies modulate early Zika virus infection of mice
20. Emergence of Oseltamivir-Resistant H7N9 Influenza Viruses in Immunosuppressed Cynomolgus Macaques
21. Fetal Growth Restriction Caused by Sexual Transmission of Zika Virus in Mice
22. Evaluation of seasonal influenza vaccines for H1N1pdm09 and type B viruses based on a replication-incompetent PB2-KO virus
23. A Bivalent Vaccine Based on a PB2-Knockout Influenza Virus Protects Mice From Secondary Pneumococcal Pneumonia
24. AgBR1 antibodies delay lethal Aedes aegypti-borne West Nile virus infection in mice
25. Hemozoin as a novel adjuvant for inactivated whole virion influenza vaccine
26. Research article antibody induction and immune response in nasal cavity by third dose of SARS-CoV-2 mRNA vaccination.
27. In vitro and in vivo characterization of SARS-CoV-2 strains resistant to nirmatrelvir.
28. Mature dendritic cells enriched in regulatory molecules may control regulatory T cells and the prognosis of head and neck cancer.
29. Characterization of H7N9 influenza A viruses isolated from humans
30. Humoral immune evasion of the omicron subvariants BQ.1.1 and XBB.
31. Foxp3+ CD4+ regulatory T cells control dendritic cells in inducing antigen-specific immunity to emerging SARS-CoV-2 antigens.
32. Characterization of a SARS-CoV-2 EG.5.1 clinical isolate in vitro and in vivo.
33. Efficacy of antivirals and bivalent mRNA vaccines against SARS-CoV-2 isolate CH.1.1.
34. Antiviral and bivalent vaccine efficacy against an omicron XBB.1.5 isolate.
35. Aedes aegypti NeSt1 protein enhances Zika virus pathogenesis by activating neutrophils.
36. Altered vector competence in an experimental mosquito-mouse transmission model of Zika infection.
37. Human protective monoclonal antibodies against the HA stem of group 2 HAs derived from an H3N2 virus-infected human.
38. TAM Receptors Are Not Required for Zika Virus Infection in Mice.
39. A Bivalent Vaccine Based on a PB2-Knockout Influenza Virus Protects Mice From Secondary Pneumococcal Pneumonia.
40. A Novel Bivalent Vaccine Based on a PB2-Knockout Influenza Virus Protects Mice from Pandemic H1N1 and Highly Pathogenic H5N1 Virus Challenges.
41. Blocking of FcR Suppresses the Intestinal Invasion of Scrapie Agents.
42. TRiC/CCT Complex, a Binding Partner of NS1 Protein, Supports the Replication of Zika Virus in Both Mammalians and Mosquitoes.
43. Subclade 2.2.1-Specific Human Monoclonal Antibodies That Recognize an Epitope in Antigenic Site A of Influenza A(H5) Virus HA Detected between 2015 and 2018.
44. Amino acids substitutions in the PB2 protein of H7N9 influenza A viruses are important for virulence in mammalian hosts.
45. A replication-incompetent influenza virus bearing the HN glycoprotein of human parainfluenza virus as a bivalent vaccine.
46. Oxidative damage to neurons caused by the induction of microglial NADPH oxidase in encephalomyocarditis virus infection
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.